1. Three-Country Snapshot of Ornithine Transcarbamylase Deficiency.
- Author
-
Seker Yilmaz, Berna, Baruteau, Julien, Arslan, Nur, Aydin, Halil Ibrahim, Barth, Magalie, Bozaci, Ayse Ergul, Brassier, Anais, Canda, Ebru, Cano, Aline, Chronopoulou, Efstathia, Connolly, Grainne M., Damaj, Lena, Dawson, Charlotte, Dobbelaere, Dries, Douillard, Claire, Eminoglu, Fatma Tuba, Erdol, Sahin, Ersoy, Melike, Fang, Sherry, and Feillet, François
- Subjects
- *
ORNITHINE , *MEDICAL care - Abstract
While, for both patients in Turkey and in the UK, dual therapy with a combination of sodium benzoate and sodium/glycerol phenylbutyrate was favoured, almost 30% of the patients were only on sodium benzoate in France (Figure 6). 4. Disease Management While 69% of patients in France and 79% of the ones in Turkey were receiving protein restriction, 42% of the OTCD patients in the UK were on a protein-restricted diet (Figure 5). Family history of OTCD was reported in 36% of the patients from France, 45% of the patients from Turkey and 60% of the total number of patients in the UK. 45%, 64% and 43% of the patients were under the age of 18 years old in France, Turkey and the UK, respectively whereas Turkey has the highest number of patients in the 0-6 years old group with 26%, followed by the UK with 19% and France with 11% (Figure 2). 3.2. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF